June 5th PROGRAM:
8:15am | MODULE 1
Management of Low-Risk Thyroid Cancer –Observation, RFA or Surgery
Chairs: Mike Tuttle and Bryan McIver
Rapporteur: Amanda Silver
Keynote: Megan Haymart, The role of patient factors in clinical decision making
Panel: Akira Miyauchi, Fernanda Vaisman, Laszlo Hegedus, Tracy Wang,
Kepal Patel
Topics: Preoperative Evaluation (ETE, Nodal Disease), Active Surveillance vs RFA vs Surgery, Patient Centric Outcomes, Hemi vs Total, Adjuvant Therapy – RAI and TSH Suppression, Monitoring / Surveillance
10:45am | MODULE 2
Medullary Thyroid Carcinoma
Chairs: Naifa Busaidy and Jeremy Freeman
Rapporteur: Nidal Muhanna
Keynote: Lori Wirth, RET inhibitor therapy for advanced and metastatic MTC
Panel: Jatin Shah, Cherie Ann Nathan, Rossella Elisei, Kerstin Lorenz, Peter Kopp
Topics: Preoperative Evaluation/Cytology, Management of Neck Nodes, Monitoring / Surveillance, MEN Syndromes – Genotype Phenotype Correlations, Paraneoplastic Symptoms Management
1:15pm | MODULE 3
The Future of Surgery: IRCAD at the WCTC
Chairs: Jacques Marescaux and Gregory Randolph
Rapporteur: Daniel Rocke
Introduction: Imaging, Robotics and Artificial Intelligence, the 3 Weapons of choice to achieve Digital Surgery, Jacques Marescaux, President and Founder of IRCAD
Keynote: Virtual and Augmented Reality applied to Endocrine Surgery, Luc Soler, Former Scientific Director of IRCAD, Professor at the University of Strasbourg
Keynote: Towards Precision Endocrine Neck Surgery with Optical Imaging and Deep Learning, Michele Diana, Medical-Scientific Director of IRCAD
Panel: IRCAD Faculty, Ashok Shaha, Brendan Stack, Mike Singer, Teresa Kroeker, Julia Noel, Jeremy Freeman, Ian Witterick
Topics: Remote Access Surgery, Robotics, AI, Virtual Surgery – How to Implement and How to Train
Each Module will be followed by an Audience Chat, Product Theatre and Virtual Exhibits.
|